Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer

Clinical trial NCT01661868 · WITHDRAWN

Trial details

NCT number: NCT01661868
Sponsor: Dana-Farber Cancer Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Peritoneal Cancer Fallopian Tube Cancer

Start date: 2012-08-01
Primary completion: 2012-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.